Sort by: after hours % change | delayed % change | gain open | gain high | gain close | publishing date
tags : Therapeutics symbols : Sny save search
BrainStorm Cell Therapeutics Announces Management Changes as Company Plans Registrational Phase 3b Trial of NurOwn
Published: 2024-04-16 (Just crawled : 23:00) - prnewswire.com
BCLI | $0.5275 -3.86% -4.02% 620K
|
Health Technology
| Email alert
Add to watchlist
SNYNF | $92.966 -2.18% 630
|
Health Technology
| Email alert
Add to watchlist
SNY | $45.81 -0.93% -0.94% 1.4M
|
Health Technology
| Email alert
Add to watchlist
management company cell nurown trial therapeutics
Biologic Therapeutics Market size is set to grow by USD 286.12 billion from 2023-2027, Introduction of biosimilars boost the market, Technavio
Published: 2024-04-15 (Crawled : 22:00) - prnewswire.com
NVS | $93.2 -1.28% 0.0% 1.6M
|
Health Technology
|
| O: -1.46%
H: 0.0%
C: 0.0%
GSK | $39.95 -1.36% 0.0% 2.4M
|
Health Technology
|
| O: -1.63%
H: 0.0%
C: 0.0%
SNY | $45.81 -0.93% -0.94% 1.4M
|
Health Technology
|
| O: -2.13%
H: 0.0%
C: 0.0%
AZN | $68.27 -0.67% -0.67% 3.8M
|
Health Technology
|
| O: -0.77%
H: 0.0%
C: 0.0%
set therapeutics market
Gastrointestinal Therapeutics and Diagnostics: Propelling Global Markets with Cutting-Edge Technologies by BCC Research LLC
Published: 2024-04-15 (Crawled : 11:00) - prnewswire.com
SNYNF | $92.966 -2.18% 630
|
Health Technology
|
| O: -0.53%
H: 0.61%
C: 0.61%
JNJ | $144.45 -2.13% 0.03% 13M
|
Health Technology
|
| O: -0.04%
H: 0.0%
C: 0.0%
ABBV | $162.54 0.54% 0.0% 4.8M
|
Health Technology
|
| O: 0.13%
H: 0.11%
C: -1.73%
SNY | $45.81 -0.93% -0.94% 1.4M
|
Health Technology
|
| O: 1.95%
H: 0.0%
C: 0.0%
research global gastrointestinal therapeutics
Orna Therapeutics Appoints Frank Neumann, M.D., Ph.D., as Chief Medical Officer
Published: 2024-04-11 (Crawled : 20:00) - biospace.com/
SNYNF | $92.966 -2.18% 630
|
Health Technology
|
| O: -0.9%
H: 0.0%
C: -0.54%
VSTM | $10.94 -1.17% -1.19% 64K
|
Health Technology
|
| O: -0.4%
H: 4.84%
C: 4.79%
SNY | $45.81 -0.93% -0.94% 1.4M
|
Health Technology
|
| O: 0.05%
H: 0.0%
C: 0.0%
medical therapeutics
Nurix Therapeutics Reports First Quarter Fiscal 2024 Financial Results and Provides a Corporate Update
Published: 2024-04-10 (Crawled : 11:00) - globenewswire.com
SNYNF | $92.966 -2.18% 630
|
Health Technology
|
| O: -0.01%
H: 0.0%
C: 0.0%
SNY | $45.81 -0.93% -0.94% 1.4M
|
Health Technology
|
| O: -0.32%
H: 0.0%
C: 0.0%
NRIX 2 d | $14.67 -5.11% -5.39% 1.3M
|
Health Technology
|
| O: 18.35%
H: 1.98%
C: -5.88%
first update therapeutics financial results
Nurix Therapeutics Announces Extension of Strategic Collaboration with Sanofi to Develop Novel Targeted Protein Degraders of STAT6
Published: 2024-04-09 (Crawled : 11:00) - globenewswire.com
SNYNF | $92.966 -2.18% 630
|
Health Technology
|
| O: 0.28%
H: 0.0%
C: 0.0%
SNY | $45.81 -0.93% -0.94% 1.4M
|
Health Technology
|
| O: -0.38%
H: 0.95%
C: 0.83%
NRIX 2 d | $14.67 -5.11% -5.39% 1.3M
|
Health Technology
|
| O: 1.26%
H: 0.0%
C: 0.0%
protein collaboration extension therapeutics sanofi
Eczema Therapeutics Market size is set to grow by USD 5.81 bn from 2024-2028,high prevalence of atopic dermatitis boost the market- Technavio
Published: 2024-04-08 (Crawled : 18:00) - prnewswire.com
SNYNF | $92.966 -2.18% 630
|
Health Technology
|
| O: 2.24%
H: 0.0%
C: -0.8%
AZNCF | $135.94 -4.19% 770
|
Health Technology
|
| O: -3.43%
H: 6.21%
C: 6.21%
VTRS | $11.12 -1.77% -1.8% 6.8M
|
Health Technology
|
| O: -0.25%
H: 1.1%
C: -0.17%
NVS | $93.2 -1.28% 0.0% 1.6M
|
Health Technology
|
| O: -0.05%
H: 0.43%
C: -0.27%
BMY | $48.26 -0.52% 0.04% 12M
|
Health Technology
|
| O: -0.08%
H: 0.04%
C: -0.35%
BHC | $8.74 1.28% 0.11% 2.5M
|
Health Technology
|
| O: 0.38%
H: 0.0%
C: -7.27%
ABBV | $162.54 0.54% 0.0% 4.8M
|
Health Technology
|
| O: 0.77%
H: 1.63%
C: 0.35%
SNY | $45.81 -0.93% -0.94% 1.4M
|
Health Technology
|
| O: 0.84%
H: 0.0%
C: 0.0%
AZN | $68.27 -0.67% -0.67% 3.8M
|
Health Technology
|
| O: 0.18%
H: 0.3%
C: 0.19%
eczema dermatitis set therapeutics market
OMass Therapeutics expands Scientific Advisory Board with the appointment of Sarah Teichmann
Published: 2024-04-08 (Crawled : 09:00) - biospace.com/
SNYNF | $92.966 -2.18% 630
|
Health Technology
|
| O: 2.24%
H: 0.0%
C: -0.8%
SNY | $45.81 -0.93% -0.94% 1.4M
|
Health Technology
|
| O: 0.84%
H: 0.0%
C: 0.0%
therapeutics
Odyssey Therapeutics Appoints Julie Clauss as Chief Operating Officer and Christopher Butler as SVP, Head of Chemistry
Published: 2024-04-02 (Crawled : 14:30) - biospace.com/
SNY | $45.81 -0.93% -0.94% 1.4M
|
Health Technology
|
| O: -1.14%
H: 0.02%
C: -1.06%
therapeutics
Global Acute Lymphoblastic Leukemia Therapeutics Market Research 2024-2033: Developments Review, Regulatory Landscape, Competitive Benchmarking, Dynamic Landscape
Published: 2024-03-29 (Crawled : 18:00) - prnewswire.com
BMY | $48.26 -0.52% 0.04% 12M
|
Health Technology
| Email alert
Add to watchlist
GILD | $67.32 -0.64% -0.64% 5M
|
Health Technology
| Email alert
Add to watchlist
SNYNF | $92.966 -2.18% 630
|
Health Technology
| Email alert
Add to watchlist
AMGN | $265.64 0.05% 0.05% 2M
|
Health Technology
| Email alert
Add to watchlist
GMAB | $29.42 -0.31% -0.31% 340K
|
Health Technology
| Email alert
Add to watchlist
SNY | $45.81 -0.93% -0.94% 1.4M
|
Health Technology
| Email alert
Add to watchlist
NVSEF | $93.6375 6.88% 82K
|
Health Technology
| Email alert
Add to watchlist
NVS | $93.2 -1.28% 0.0% 1.6M
|
Health Technology
| Email alert
Add to watchlist
GNMSF | $282.004 3.83% 210
|
Health Technology
| Email alert
Add to watchlist
ABBV | $162.54 0.54% 0.0% 4.8M
|
Health Technology
| Email alert
Add to watchlist
research global leukemia therapeutics market
Dyne Therapeutics Announces CEO Transition
Published: 2024-03-25 (Crawled : 12:00) - globenewswire.com
SNYNF | $92.966 -2.18% 630
|
Health Technology
|
| O: -100.0%
H: NaN%
C: Infinity%
SNY | $45.81 -0.93% -0.94% 1.4M
|
Health Technology
|
| O: 0.42%
H: 0.0%
C: 0.0%
DYN | $24.63 -3.18% -3.29% 930K
|
Health Technology
|
| O: -13.24%
H: 11.02%
C: 6.37%
BIIB | $195.16 -0.83% -0.85% 870K
|
Health Technology
|
| O: -0.15%
H: 0.23%
C: -0.5%
ceo therapeutics
Mirador Therapeutics Launches to Accelerate the Next Generation of Precision Medicines for Immune-mediated Diseases
Published: 2024-03-21 (Crawled : 12:30) - biospace.com/
SNYNF | $92.966 -2.18% 630
|
Health Technology
|
| O: 0.14%
H: 0.24%
C: 0.24%
SNY | $45.81 -0.93% -0.94% 1.4M
|
Health Technology
|
| O: 0.3%
H: 0.0%
C: 0.0%
precision therapeutics
CytomX Therapeutics Appoints Dr. Zhen Su to Board of Directors
Published: 2024-03-21 (Crawled : 12:00) - globenewswire.com
SNYNF | $92.966 -2.18% 630
|
Health Technology
|
| O: 0.14%
H: 0.24%
C: 0.24%
SNY | $45.81 -0.93% -0.94% 1.4M
|
Health Technology
|
| O: 0.3%
H: 0.0%
C: 0.0%
CTMX | $1.865 -5.33% -5.63% 340K
|
Health Technology
|
| O: -1.76%
H: 3.59%
C: 0.45%
therapeutics
Monoclonal Antibody (mABs) Therapeutics Market Worth $497.5 billion | MarketsandMarkets™
Published: 2024-03-15 (Crawled : 14:30) - prnewswire.com
TAK | $13.23 0.38% 0.0% 2.3M
|
Health Technology
|
| O: 0.21%
H: 0.97%
C: 0.7%
NVS | $93.2 -1.28% 0.0% 1.6M
|
Health Technology
|
| O: 0.05%
H: 0.14%
C: -0.93%
JNJ | $144.45 -2.13% 0.03% 13M
|
Health Technology
|
| O: -1.58%
H: 0.0%
C: 0.0%
LLY | $746.74 -0.54% 1.01% 2.5M
|
Health Technology
|
| O: -0.7%
H: 0.73%
C: -0.16%
ABBV | $162.54 0.54% 0.0% 4.8M
|
Health Technology
|
| O: -0.07%
H: 0.0%
C: 0.0%
SNY | $45.81 -0.93% -0.94% 1.4M
|
Health Technology
|
| O: -0.02%
H: 0.0%
C: 0.0%
REGN | $894.265 -0.48% -0.48% 610K
|
Health Technology
|
| O: -0.27%
H: 1.26%
C: 0.84%
AMGN | $265.64 0.05% 0.05% 2M
|
Health Technology
|
| O: 0.2%
H: 1.14%
C: -1.18%
antibody therapeutics market
Sangamo Therapeutics Reports Recent Business Highlights and Fourth Quarter and Full Year 2023 Financial Results
Published: 2024-03-13 (Crawled : 13:00) - biospace.com/
SNY | $45.81 -0.93% -0.94% 1.4M
|
Health Technology
|
| O: -0.04%
H: 0.0%
C: 0.0%
SGMO | $0.5422 -2.32% -2.38% 990K
|
Health Technology
|
| O: 2.19%
H: 4.55%
C: -10.78%
business year therapeutics financial results
AnHeart Therapeutics and Innovent Announce China’s NMPA has Accepted Second New Drug Application for Taletrectinib for First-Line Treatment of ROS1-Positive Lung Cancer
Published: 2024-03-05 (Crawled : 08:00) - biospace.com/
SNY | $45.81 -0.93% -0.94% 1.4M
|
Health Technology
|
| O: 1.17%
H: 0.0%
C: 0.0%
lung drug cancer treatment application therapeutics
Innovent and AnHeart Therapeutics Announce the NMPA of China Has Accepted Second NDA for Taletrectinib for First-Line Treatment of ROS1-Positive Lung Cancer
Published: 2024-03-05 (Crawled : 06:00) - prnewswire.com
SNY | $45.81 -0.93% -0.94% 1.4M
|
Health Technology
|
| O: 1.17%
H: 0.0%
C: 0.0%
INCY | $53.23 -0.37% -0.38% 1.5M
|
Health Technology
|
| O: 0.4%
H: 0.38%
C: -1.77%
lung cancer treatment therapeutics china
Denali Therapeutics Reports Fourth Quarter and Full Year 2023 Financial Results and Business Highlights
Published: 2024-02-27 (Crawled : 13:00) - globenewswire.com
SNY | $45.81 -0.93% -0.94% 1.4M
|
Health Technology
|
| O: -0.94%
H: 0.0%
C: 0.0%
DNLI | $17.35 -2.75% -2.82% 1.1M
|
Health Technology
|
| O: 18.06%
H: 17.95%
C: 17.1%
business year therapeutics financial results
Kymera Therapeutics Announces Fourth Quarter and Full Year 2023 Financial Results and Provides a Business Update
Published: 2024-02-22 (Crawled : 12:00) - globenewswire.com
SNYNF | $92.966 -2.18% 630
|
Health Technology
|
| O: 0.26%
H: 1.36%
C: 1.36%
SNY | $45.81 -0.93% -0.94% 1.4M
|
Health Technology
|
| O: 1.67%
H: 0.0%
C: 0.0%
KYMR | $33.92 -1.37% -1.39% 490K
|
Health Technology
|
| O: 2.92%
H: 7.24%
C: 1.73%
business year update therapeutics financial results
Colorectal Cancer Therapeutics Market Set for Growth, New Report Analyzes 8MM Forecast to 2031: Focus on United States, France, Germany, Italy, Spain, United Kingdom, Japan, and China
Published: 2024-02-19 (Crawled : 00:00) - prnewswire.com
SNYNF | $92.966 -2.18% 630
|
Health Technology
|
| O: 2.72%
H: 0.0%
C: -0.8%
SNY | $45.81 -0.93% -0.94% 1.4M
|
Health Technology
|
| O: 2.53%
H: 0.0%
C: 0.0%
report cancer set therapeutics china market
Gainers vs Losers
| 58% | 42% |
Top 10 Gainers
WISA 4 | $6.06 246.29% 71.12% 200M
|
Electronic Technology
VIAO | $0.265 -13.96% 35.85% 960K
|
Electronic Technology
JAGX | $0.178 49.83% 33.26% 600M
|
Health Technology
SXTC | $1.68 43.59% 30.36% 34M
|
Health Technology
DYNT | $0.531 43.36% 30.24% 22M
|
Health Technology
KA | $0.4796 41.06% 29.11% 5.3M
|
Manufacturing
PALI | $5.86 40.87% 29.01% 29M
|
Manufacturing
CLNN | $0.319 -3.74% 28.75% 6.3M
|
BSGM | $1.52 38.18% 27.63% 3.3M
|
Health Technology
MCBC | $13.67 37.66% 27.36% 2.2M
|
Finance
Your saved searches
Save your searches and get alerts when important news are released.